Edwards Lifesciences (EW) Misses Q4 EPS by 3c

Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $1.46, $0.03 worse than the analyst estimate of $1.49. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.14 billion.

“The December quarter results reflect strong execution in our product roadmap, success in increasing our hard drive gross margin, and an improving flash market,” said Steve Milligan, chief executive officer, Western Digital. “We expect an accelerated recovery in our flash gross margins, which coupled with ongoing strength in demand for both hard drives and flash, positions us well for continued profitable growth in calendar year 2020.”

GUIDANCE:

Edwards Lifesciences sees FY2020 EPS of $6.15-$6.40, versus the consensus of $6.16. Edwards Lifesciences sees FY2020 revenue of $4.6-5 billion, versus the consensus of $4.78 billion.

For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Nike names former Pfizer CFO David Denton as new finance chief
• Cerebras Q1 EPS miss sends shares down 9% after-hours